Hims & Hers Health News and Telehealth & Digital Wellness Industry Updates

19.73
0.00
0.00 %
Daily range
Weekly range
  • Ciaran Ryan
  • 2 hours ago
Hims & Hers Health stock consolidates as mixed momentum signals persist
Hims & Hers Health (HIMS) stock is trading at $19.73, unchanged on the day. The price sits below its key moving averages, indicating continued pressure in the current ...
  • Hlib Chabaniuk
  • 13.11.2026
Can margin pressures and insider selling trigger further losses for HIMS?
Hims & Hers Health (HIMS) stock is trading at $19.73 after a daily decline of 5.19%. The price sits below all its key moving averages, reflecting persistent weakness ...
  • Anastasiia Chabaniuk
  • 12.11.2026
Hims & Hers Health shares drop over 4% after Q3 results miss analyst expectations
Hims & Hers Health Inc (HIMS) fell 4.37% after third-quarter results missed analyst expectations with revenue and earnings declines. The move is supported by persistent bearish structure, with the ...
  • Hlib Chabaniuk
  • 12.11.2026
Hims & Hers Health reports strong revenue, new treatments: Can HIMS sustain recent gains?
Hims & Hers Health (HIMS) stock is trading at $20.81 after surging 8.73% on the day. The price finished near the top of the daily range and currently sits above its ...
  • Yaroslav Dmytrenko
  • 11.11.2026
Hims & Hers Health shares gain more than 3% after reporting strong international expansion and new deal announcements
Hims & Hers Health Inc (HIMS) advanced 3.29% after reporting a 49% surge in third-quarter 2026 revenue, driven by international expansion and new partnerships. The rebound looks limited, as the ...
  • Ciaran Ryan
  • 11.11.2026
Hims & Hers stock outlook: Downside risk rises on earnings miss and bearish momentum
Hims & Hers (HIMS) stock is trading at $19.13 after a sharp fall of 16.59% on the session, closing deeply in the red. The price sits well below its key moving averages, ...
  • Ashutosh Sureka
  • 10.11.2026
HIMS slides around 9.5% as shift to GLP-1 drugs and margin contraction drive selloff
Hims & Hers Health Inc (HIMS) fell 9.44% after Q3 2026 results missed analyst expectations, driven by a swing to net loss, lowered full-year guidance, and margin contraction following its ...
  • Ivan Andriyenko
  • 10.11.2026
Hims & Hers trims 2026 revenue forecast: Can HIMS fall further?
Hims & Hers (HIMS) stock is trading at $22.94 after falling 11.75% on the day. The stock closed below its key moving averages, reflecting sustained weakness within the ...
  • Ashutosh Sureka
  • 09.11.2026
HIMS slides nearly 7% amid bearish technical signals and high short interest
Hims & Hers Health Inc (HIMS) fell 6.64% after opening lower, as sellers dominated in advance of the company’s third-quarter earnings release. The decline is supported by the stock trading below ...
  • Aleksandra Chaikina
  • 09.11.2026
Hims & Hers stock outlook: Upward price move faces resistance at $28.53
Hims & Hers (HIMS) stock is trading at $26, marking a daily advance of 8.06%. The price sits above its key short-term moving average, while remaining below intermediate ...
  • Ezequiel Gomes
  • 06.11.2026
HIMS climbs over 4% after unveiling four new Benefits platform partnerships
Hims & Hers Health Inc (HIMS) climbed 4.03% as investors responded to the expansion of its Benefits platform with four new partners, which increased its program offerings for subscribers. The ...
  • Mikhail Vnuchkov
  • 06.11.2026
Will Hims & Hers Health stock face deeper losses as weak momentum dominates?
Hims & Hers Health (HIMS) stock is trading at $24.06 after a sharp decline of 9.74% today. The price remains below its key moving averages, signaling continued downside ...
  • Aleksandra Chaikina
  • 05.11.2026
Why is Hims & Hers Health stock down 4.8% today?
Hims & Hers Health Inc (HIMS) fell 4.82% after selling pressure intensified on renewed legal headline risk and ahead of the company’s upcoming third quarter 2026 earnings release. The move is ...
  • Aleksandra Chaikina
  • 05.11.2026
Hims & Hers Health stock tests $26.9 resistance amid mixed technical signals
Hims & Hers Health (HIMS) stock is trading at $26.66, up 3.57% for the day. The price currently sits above its key short-term moving average but remains below both ...
  • Sholanke Dele
  • 04.11.2026
Why is Hims & Hers Health stock up 9.6% today?
Hims & Hers Health Inc (HIMS) surged 9.67% after investors positioned ahead of its upcoming third quarter 2026 earnings release, drawing renewed attention to the company. The rebound looks ...
  • Parshwa Turakhiya
  • 04.11.2026
Hims & Hers Health shares technical analysis: Upward price move faces $27.64 resistance
Hims & Hers Health (HIMS) stock is trading at $25.7, advancing 1.84% on the session. The price remains below its key moving averages, reflecting ongoing downward ...
  • Oleg Tkachenko
  • 03.11.2026
HIMS climbs over 4% after investors eye earnings release and legal updates
Hims & Hers Health Inc. (HIMS) jumped 4.16% as investors positioned ahead of its upcoming third quarter 2026 earnings release and weighed ongoing legal developments. The rebound looks limited, ...
  • Ivan Andriyenko
  • 03.11.2026
Hims & Hers Health stock drops as Q3 2026 earnings caution adds to volatility
Hims & Hers Health (HIMS) stock is trading at $25.24, posting a sharp decline of 8.85% for the day. The price remains below its key moving averages, underscoring ongoing ...
  • Anastasiia Chabaniuk
  • 02.11.2026
What's behind Hims & Hers's latest stock pullback?
Hims & Hers Health Inc (HIMS) dropped 3.27% as investors responded to upcoming third quarter earnings and ongoing securities class action lawsuits involving the company. The down move is ...
  • Mykhailo Ihnatenko
  • 02.11.2026
Hims & Hers Health stock price prediction: Weak momentum flags further downside risk
Hims & Hers Health (HIMS) stock is trading at $27.68, down 6.77% for the session. The price currently sits below its short- and medium-term moving averages, while ...
  • Anton Kharitonov
  • 30.10.2026
Why is Hims & Hers Health stock down 5.2% today?
Hims & Hers Health Inc (HIMS) fell 5.25% following renewed investor attention on multiple securities class action lawsuits and related legal concerns. The decline is supported by short- and ...